Dianthus Therapeutics DNTH Other Costs — General And Administrative Expense
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Dianthus Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dianthus Therapeutics's other costs — general and administrative expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Dianthus Therapeutics's other costs — general and administrative expense?
- Dianthus Therapeutics (DNTH) reported other costs — general and administrative expense of $2.65M in Q1 2026.
- How has Dianthus Therapeutics's other costs — general and administrative expense changed year-over-year?
- Dianthus Therapeutics's other costs — general and administrative expense increased by 37.0% year-over-year, from $1.94M to $2.65M.
- What does other costs — general and administrative expense mean?
- This metric encompasses the overhead costs associated with the company's corporate operations, including executive management, legal, human resources, and general office expenses. It reflects the fixed cost structure required to support the organization's infrastructure and regulatory compliance as a public entity. Tracking this metric is essential for evaluating the company's operational leverage and the efficiency of its corporate management.